Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1−SMAD1 interaction

Abstract

Hypertrophic differentiation is not only the terminal process of endochondral ossification in the growth plate but is also an important pathological change in osteoarthritic cartilage. Collagen type II (COL2A1) was previously considered to be only a structural component of the cartilage matrix, but recently, it has been revealed to be an extracellular signaling molecule that can significantly suppress chondrocyte hypertrophy. However, the mechanisms by which COL2A1 regulates hypertrophic differentiation remain unclear. In our study, a Col2a1 p.Gly1170Ser mutant mouse model was constructed, and Col2a1 loss was demonstrated in homozygotes. Loss of Col2a1 was found to accelerate chondrocyte hypertrophy through the bone morphogenetic protein (BMP)-SMAD1 pathway. Upon interacting with COL2A1, integrin β1 (ITGB1), the major receptor for COL2A1, competed with BMP receptors for binding to SMAD1 and then inhibited SMAD1 activation and nuclear import. COL2A1 could also activate ITGB1-induced ERK1/2 phosphorylation and, through ERK1/2-SMAD1 interaction, it further repressed SMAD1 activation, thus inhibiting BMP-SMAD1-mediated chondrocyte hypertrophy. Moreover, COL2A1 expression was downregulated, while chondrocyte hypertrophic markers and BMP-SMAD1 signaling activity were upregulated in degenerative human articular cartilage. Our study reveals novel mechanisms for the inhibition of chondrocyte hypertrophy by COL2A1 and suggests that the degradation and decrease in COL2A1 might initiate and promote osteoarthritis progression.

Breaking a destructive cycle

A signaling feedback loop that contributes to cartilage degeneration may offer a fruitful target for the treatment of osteoarthritis. During the early stages of this disorder, cartilage-forming chondrocytes undergo a process of expansion known as hypertrophy, after which they die and are replaced by calcium. Researchers led by Peiqiang Su and Dongsheng Huang of Sun Yat-sen University have demonstrated that COL2A1, an important structural protein, represents an important safeguard against hypertrophy. COL2A1 helps maintain chondrocytes in their normal, healthy state, but Su and Huang showed that signaling factors produced during cartilage repair can reduce COL2A1 levels. This in turn accelerates hypertrophy, promoting further depletion of COL2A1 and ultimately leading to full-blown osteoarthritis. Drugs that break this cycle and preserve COL2A1 could thus help protect endangered joints before the damage becomes severe.

References

[1] Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int. J. Biochem. Cell Biol., 2008, 40:46-62

[2] Mackie EJ, Tatarczuch L, Mirams M. The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J. Endocrinol., 2011, 211:109-121

[3] Tchetina EV, Squires G, Poole AR. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J. Rheumatol., 2005, 32:876-886

[4] Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthr. Cartil., 2009, 17:971-979

[5] van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthr. Cartil., 2012, 20:223-232

[6] Dreier R. Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders. Arthritis Res. Ther., 2010, 12:216

[7] van der Kraan PM, Davidson ENB, van den Berg WB. A role for age-related changes in TGFbeta signaling in aberrant chondrocyte differentiation and osteoarthritis. Arthritis Res. Ther., 2010, 12:201

[8] Aigner T, Stove J. Collagens—major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv. Drug Deliv. Rev., 2003, 55:1569-1593

[9] van den Berg WB. Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthr. Cartil., 2011, 19:338-341

[10] Garamszegi N et al. Extracellular matrix-induced transforming growth factor-beta receptor signaling dynamics. Oncogene, 2010, 29:2368-2380

[11] Klatt AR et al. Discoidin domain receptor 2 mediates the collagen II-dependent release of interleukin-6 in primary human chondrocytes. J. Pathol., 2009, 218:241-247

[12] Xin W, Heilig J, Paulsson M, Zaucke F. Collagen II regulates chondroycte integrin expression profile and differentiation. Connect. Tissue Res., 2015, 56:307-314

[13] Chiu LH et al. Differential effect of ECM molecules on re-expression of cartilaginous markers in near quiescent human chondrocytes. J. Cell. Physiol., 2011, 226:1981-1988

[14] Enomoto M, Leboy PS, Menko AS, Boettiger D. Beta 1 integrins mediate chondrocyte interaction with type I collagen, type II collagen, and fibronectin. Exp. Cell Res., 1993, 205:276-285

[15] Loeser RF. Chondrocyte integrin expression and function. Biorheology, 2000, 37:109-116

[16] Park MS, Kim YH, Lee JW. FAK mediates signal crosstalk between type II collagen and TGF-beta 1 cascades in chondrocytic cells. Matrix Biol., 2010, 29:135-142

[17] Kim YH, Lee JW. Targeting of focal adhesion kinase by small interfering RNAs reduces chondrocyte redifferentiation capacity in alginate beads culture with type II collagen. J. Cell. Physiol., 2009, 218:623-630

[18] Raducanu A, Hunziker EB, Drosse I, Aszodi A. Beta1 integrin deficiency results in multiple abnormalities of the knee joint. J. Biol. Chem., 2009, 284:23780-23792

[19] Bengtsson T et al. Loss of α10β1 integrin expression leads to moderate dysfunction of growth plate chondrocytes. J. Cell Sci., 2005, 118:929-936

[20] Aszodi A, Hunziker EB, Brakebusch C, Fassler R. β1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes Dev., 2003, 17:2465-2479

[21] Liang G et al. Endoplasmic reticulum stress-unfolding protein response-apoptosis cascade causes chondrodysplasia in a col2a1 p.Gly1170Ser mutated mouse model. PLoS ONE, 2014, 9:e86894

[22] Li SW et al. Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev., 1995, 9:2821-2830

[23] Shin SY, Pozzi A, Boyd SK, Clark AL. Integrin alpha1beta1 protects against signs of post-traumatic osteoarthritis in the female murine knee partially via regulation of epidermal growth factor receptor signalling. Osteoarthr. Cartil., 2016, 24:1795-1806

[24] Zemmyo M, Meharra EJ, Kuhn K, Creighton-Achermann L, Lotz M. Accelerated, aging-dependent development of osteoarthritis in alpha1 integrin-deficient mice. Arthritis Rheum., 2003, 48:2873-2880

[25] Candela ME et al. Alpha 5 integrin mediates osteoarthritic changes in mouse knee joints. PLoS ONE, 2016, 11:e0156783

[26] van der Kraan PM, Davidson ENB, Blom A, van den Berg WB. TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthr. Cartil., 2009, 17:1539-1545

[27] Jing J et al. BMP receptor 1A determines the cell fate of the postnatal growth plate. Int. J. Biol. Sci., 2013, 9:895-906

[28] Nishimura R, Hata K, Matsubara T, Wakabayashi M, Yoneda T. Regulation of bone and cartilage development by network between BMP signalling and transcription factors. J. Biochem., 2012, 151:247-254

[29] van der Kraan PM, Davidson ENB, van den Berg WB. Bone morphogenetic proteins and articular cartilage: to serve and protect or a wolf in sheep clothing’s? Osteoarthr. Cartil., 2010, 18:735-741

[30] Schmierer B, Hill CS. TGF β-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol., 2007, 8:970-982

[31] Kamato D et al. Transforming growth factor-beta signalling: role and consequences of Smad linker region phosphorylation. Cell Signal., 2013, 25:2017-2024

[32] Loeser RF, Gandhi U, Long DL, Yin W, Chubinskaya S. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1. Arthritis Rheumatol., 2014, 66:2201-2209

[33] Yang J et al. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Circ. Res., 2008, 102:1212-1221

[34] Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell, 2007, 25:441-454

[35] Massague J. Integration of Smad and MAPK pathways: a link and a linker revisited. Genes Dev., 2003, 17:2993-2997

[36] Wu L et al. Insights on biology and pathology of HIF-1α/-2α, TGFβ/BMP, Wnt/β-catenin, and NF-κB pathways in osteoarthritis. Curr. Pharm. Des., 2012, 18:3293-3312

[37] Zhong L, Huang X, Karperien M, Post JN. The regulatory role of signaling crosstalk in hypertrophy of MSCs and human articular chondrocytes. Int. J. Mol. Sci., 2015, 16:19225-19247

[38] Abouheif MM et al. Silencing microRNA-34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro. Rheumatology, 2010, 49:2054-2060

[39] Husa M, Petursson F, Lotz M, Terkeltaub R, Liu-Bryan R. C/EBP homologous protein drives pro-catabolic responses in chondrocytes. Arthritis Res. Ther., 2013, 15:R218

[40] Aho OM, Finnila M, Thevenot J, Saarakkala S, Lehenkari P. Subchondral bone histology and grading in osteoarthritis. PLoS ONE, 2017, 12:e0173726

[41] Chan D, Cole WG, Chow CW, Mundlos S, Bateman JF. A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage. J. Biol. Chem., 1995, 270:1747-1753

[42] Esapa CT et al. A mouse model for spondyloepiphyseal dysplasia congenita with secondary osteoarthritis due to a Col2a1 mutation. J. Bone Miner. Res., 2012, 27:413-428

[43] Chung HJ, Jensen DA, Gawron K, Steplewski A, Fertala A. R992C (p.R1192C) substitution in collagen II alters the structure of mutant molecules and induces the unfolded protein response. J. Mol. Biol., 2009, 390:306-318

[44] Donahue LR et al. A missense mutation in the mouse Col2a1 gene causes spondyloepiphyseal dysplasia congenita, hearing loss, and retinoschisis. J. Bone Miner. Res., 2003, 18:1612-1621

[45] Lee AS et al. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene, 2013, 527:440-447

[46] Su P et al. Age at onset-dependent presentations of premature hip osteoarthritis, avascular necrosis of the femoral head, or Legg-Calve-Perthes disease in a single family, consequent upon a p.Gly1170Ser mutation of COL2A1. Arthritis Rheum., 2008, 58:1701-1706

[47] Kannu P et al. Premature arthritis is a distinct type II collagen phenotype. Arthritis Rheum., 2010, 62:1421-1430

[48] Spector TD, MacGregor AJ. Risk factors for osteoarthritis: genetics. Osteoarthr. Cartil., 2004, 12:S39-S44

[49] Husar-Memmer E et al. Premature osteoarthritis as presenting sign of type II collagenopathy: a case report and literature review. Semin. Arthritis Rheum., 2013, 42:355-360

[50] Hyttinen MM et al. Inactivation of one allele of the type II collagen gene alters the collagen network in murine articular cartilage and makes cartilage softer. Ann. Rheum. Dis., 2001, 60:262-268

[51] Sekiya I, Vuoristo JT, Larson BL, Prockop DJ. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc. Natl Acad. Sci. USA, 2002, 99:4397-4402

[52] Mueller MB, Tuan RS. Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum., 2008, 58:1377-1388

[53] Zuscik MJ et al. 5-azacytidine alters TGF-β and BMP signaling and induces maturation in articular chondrocytes. J. Cell Biochem., 2004, 92:316-331

[54] Wu Z et al. Melatonin-mediated miR-526b-3p and miR-590-5p upregulation promotes chondrogenic differentiation of human mesenchymal stem cells. J. Pineal Res., 2018, 65:e12483

[55] Shepherd TG, Mujoomdar ML, Nachtigal MW. Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion. J. Ovarian Res., 2010, 3

[56] Safina A, Vandette E, Bakin AV. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells. Oncogene, 2007, 26:2407-2422

Funding

China Postdoctoral Science Foundation(2017M622873)

Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(2018A0303130260)

Guangzhou Science and Technology Plan(No.201804010057); The Fundamental Research Funds for the Central Universities (No. 17ykpy06).

National Natural Science Foundation of China (National Science Foundation of China)(81802217)